<p>NAFLD = non-alcohol fatty liver disease; values are given as mean and 95% confident interval (CI). Factor 1 (Omega 7 and 9 and saturated fatty acids, total fatty acids, mono-unsaturated fatty acids); Factor 2 (isoleucine, leucine, valine, phenylalanine, tyrosine and orosomucoid); Factor 3 (acetate, alanine, lactate, pyruvate); Factor 4 (esterified cholesterol, free cholesterol, omega 6 fatty acids, phosphoglycerides, phosphocholines and sphingomyelines); Factor 5 (beta-hydroxybutyrate, citrate, histidine); Factor 6 (acetoacetate, glutamine)</p><p>Mean metabolite component levels stratified by the healthy control and NAFLD groups (MIXED model estimated marginal means with 95% confidence intervals are given taking into account shared envir...
Backgrounds: The prevalence of NAFLD is increasing in the world. The mechanism of pathogenesis and s...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease affecting ...
<p>NAFLD = non-alcohol fatty liver disease; BMI = body mass index; FM = fat mass of the whole body; ...
<p>Model 1 was adjusted for age smoking, and drinking;</p><p>Model 2 was further adjusted for BMI;</...
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that ranges in severity f...
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and...
<p>Values are expressed as mean ± SD.</p><p>NAFLD, non-alcoholic fatty liver disease; HRV, heart rat...
<p>Multivariable-adjusted models included age, sex, education, BMI, hypertension, TC/HDL-cholesterol...
<p>Results are expressed as number (percentage), mean ± SD; n = number of subjects; SGPT, serum glut...
Abstract The prevalence of non-alcoholic fatty liver disease (NAFLD) continues to increase dramatica...
Abstract The prevalence of non‐alcoholic fatty liver disease (NAFLD) continues to increase dramatica...
BACKGROUND: The central feature of NAFLD is a disturbed fatty-acid metabolism with hepatic lipid acc...
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation o...
Primary nonalcoholic fatty liver disease (NAFLD) is bi-directionally associated with the metabolic s...
Backgrounds: The prevalence of NAFLD is increasing in the world. The mechanism of pathogenesis and s...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease affecting ...
<p>NAFLD = non-alcohol fatty liver disease; BMI = body mass index; FM = fat mass of the whole body; ...
<p>Model 1 was adjusted for age smoking, and drinking;</p><p>Model 2 was further adjusted for BMI;</...
Nonalcoholic fatty liver disease (NAFLD) is a common chronic liver disease that ranges in severity f...
Background: Free fatty acid (FFA) metabolism can impact on metabolic conditions, such as obesity and...
<p>Values are expressed as mean ± SD.</p><p>NAFLD, non-alcoholic fatty liver disease; HRV, heart rat...
<p>Multivariable-adjusted models included age, sex, education, BMI, hypertension, TC/HDL-cholesterol...
<p>Results are expressed as number (percentage), mean ± SD; n = number of subjects; SGPT, serum glut...
Abstract The prevalence of non-alcoholic fatty liver disease (NAFLD) continues to increase dramatica...
Abstract The prevalence of non‐alcoholic fatty liver disease (NAFLD) continues to increase dramatica...
BACKGROUND: The central feature of NAFLD is a disturbed fatty-acid metabolism with hepatic lipid acc...
Introduction and objectives: Nonalcoholic fatty liver disease (NAFLD) is the hepatic manifestation o...
Primary nonalcoholic fatty liver disease (NAFLD) is bi-directionally associated with the metabolic s...
Backgrounds: The prevalence of NAFLD is increasing in the world. The mechanism of pathogenesis and s...
Non-alcoholic fatty liver disease (NAFLD) ranges from steatosis and hepatic insulin resistance to no...
Nonalcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease affecting ...